Randall Michael Giuffre

DMAC

Randall Michael Giuffre serves as Director at DiaMedica Therapeutics Inc. (DMAC). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

5 trades

$451.3K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$451.3K

Companies Traded

DMAC

Active Period

Nov 2022 – Jun 2023

5 total trades

Most Recent

Buy DMAC

Jun 23, 2023 · $254.2K

Randall Michael Giuffre's Insider Trading at DiaMedica Therapeutics Inc. (DMAC)

Buys

5 · $451.3K

Sells

0 · $0.00

Total Shares Bought

215,000

Total Shares Sold

DMAC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jun 23, 2023	Buy	65,000	$3.91	$254.2K
Dec 8, 2022	Buy	57,079	$1.42	$81.0K
Dec 6, 2022	Buy	24,874	$1.40	$34.7K
Dec 1, 2022	Buy	819	$1.19	$974.61
Nov 29, 2022	Buy	67,228	$1.20	$80.5K

Related Insiders

STAHLBERG JAN

10% Owner

DMACBuy · Nov 17, 2025

JACINTO RICHARD II

10% Owner

DMACBuy · Jul 23, 2025

Koch Thomas Von

10% Owner

DMACBuy · Jul 23, 2025

Explore More Insider Trading Data

DMAC Insider Trading Activity

View all insider trades at DiaMedica Therapeutics Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity